newsfilter
← Latest News
GlobeNewswire·

Landos Biopharma Reports Third Quarter 2022 Results and Provides Business Update

NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ:LABP), a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, today announced